Adı́lia Hormigo
- Genetics top 1%
- Glioma Diagnosis and Treatment 28
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 7
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 5
- Cancer Research top 5%
-
- Radiomics and Machine Learning in Medical Imaging 9
- MRI in cancer diagnosis 4
-
- Brain Metastases and Treatment 6
-
- Immunotherapy and Immune Responses 6
-
- Nanoplatforms for cancer theranostics 6
- Co-authors
- Lisa M. DeAngelisLauren E. AbreyIgor T. GavrilovicShahin RafiiNicholas W. GaleDavid M. ValenzuelaJared KushnerGeorge D. Yancopoulos
- Journals
- Journal of Clinical Investigation (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (8 papers)
- Partner nations
- United StatesPortugalSwitzerland
In The Last Decade
Adı́lia Hormigo
56 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Genetics 923
- Oncology 1.0k
- Neurology 501
- Cancer Research 409
- Pathology and Forensic Medicine 417
Countries citing papers authored by Adı́lia Hormigo
This map shows the geographic impact of Adı́lia Hormigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adı́lia Hormigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adı́lia Hormigo more than expected).
Fields of papers citing papers by Adı́lia Hormigo
This network shows the impact of papers produced by Adı́lia Hormigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adı́lia Hormigo. The network helps show where Adı́lia Hormigo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adı́lia Hormigo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 19 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 9 | |
| 7 | 2020 | 29 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 8 | |
| 10 | 2018 | 6 | |
| 11 | 2016 | 28 | |
| 12 | 2012 | 74 | |
| 13 | 2011 | 16 | |
| 14 | 2009 | 128 | |
| 15 | CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumorsbreakdown → | 2008 | 731 |
| 16 | 2007 | 25 | |
| 17 | 2004 | 38 | |
| 18 | 2003 | 38 | |
| 19 | 1996 | 6 | |
| 20 | 1990 | 11 |
About Adı́lia Hormigo
Adı́lia Hormigo is a scholar working on Genetics, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (28 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Brain Metastases and Treatment (6 papers), Immunotherapy and Immune Responses (6 papers), Nanoplatforms for cancer theranostics (6 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and MRI in cancer diagnosis (4 papers). The work is most often cited by research in Genetics (923 citations), Oncology (1.0k citations) and Neurology (501 citations). Adı́lia Hormigo has collaborated with scholars based in United States, Portugal and Switzerland. Frequent co-authors include Lisa M. DeAngelis, Lauren E. Abrey, Igor T. Gavrilovic, Shahin Rafii, Nicholas W. Gale, David M. Valenzuela, Jared Kushner, George D. Yancopoulos, Till Milde and Sergey V. Shmelkov. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.